SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Take Solutions touches roof on entering into longevity and Anti-ageing market in India

17 Apr 2026 Evaluate

Take Solutions is currently trading at upper limit of Rs. 48.91, up by 0.95 points or 1.98% from its previous closing of Rs. 47.96 on the BSE.

The scrip opened at Rs. 48.91 and has touched a high and low of Rs. 48.91 and Rs. 48.85 respectively. So far 28212 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 1 has touched a 52 week high of Rs. 49.90 on 13-Feb-2026 and a 52 week low of Rs. 7.30 on 12-May-2025.

Last one week high and low of the scrip stood at Rs. 48.91 and Rs. 46.37 respectively. The current market cap of the company is Rs. 723.55 crore.

The Institutions and Non-Institutions held 0.56% and 99.44% stake in the company respectively.

Take Solutions has entered into the rapidly expanding longevity and Anti-ageing market in India. The initiative is designed to leverage the company’s established expertise in clinical research, life sciences, and regulatory processes to build a scalable platform across consumer health products and digital wellness solutions.

Take Solutions’ entry strategy is centered on a dual model that combines product innovation with technology-enabled health solutions. The company plans to develop science-backed nutraceuticals, biohacking-focused products, and predictive digital tools that can help consumers track and optimize metabolic health, sleep, cognition, and biological aging. This approach is intended to create a differentiated offering in a market that is still underpenetrated but increasingly attractive to investors due to its repeat-purchase potential and margin profile.

Take Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.

Take Solutions Share Price

29.97 0.08 (0.27%)
18-Jun-2026 15:20 View Price Chart
Peers
Company Name CMP
TCS 2206.10
Infosys 1128.10
HCL Tech. 1163.25
Wipro 182.85
Tech Mahindra 1450.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: